Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0000898432-25-000062 0001745437 XXXXXXXX LIVE 4 Class A Common Stock, par value $0.01 10/03/2025 false 0001723128 03168L105 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 Christine Krentz (908) 409-6700 4 Gatehall Drive Parsippany NJ 07054 0001745437 Patel Dipan a OO X1 23828992 0 23828992 0 23828992 N 7.6 IN The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 314,079,309 shares of Class A Common Stock outstanding, as disclosed in the New Issuer's Quarterly Report on Form 10-Q, filed on August 7, 2025. Class A Common Stock, par value $0.01 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 This Amendment No. 4 to Schedule 13D (this "Amendment No. 4") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 4, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the New Issuer. Capitalized terms used but not defined in this Amendment No. 4 shall have the meanings set forth in the Schedule 13D. The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 314,079,309 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on August 7, 2025: Reporting Person - Dipan Patel Amount Beneficially Owned - 23,828,992 Percent of Class - 7.6 Sole power to vote or to direct the vote - 23,828,992 Shared power to vote or to direct the vote - 0 Sole power to dispose or to direct the disposition - 23,828,992 Shared power to dispose or to direct the disposition - 0 The Reporting Person may be deemed to beneficially own 23,828,992 shares of Class A Common Stock held of record by trusts controlled by the Reporting Person. The information set forth in Item 6 of this Amendment No. 4 is incorporated by reference herein. The information set forth in Item 6 of this Amendment No. 4 is incorporated by reference herein. Not applicable. Item 6 of the Schedule 13D is hereby amended and supplemented by adding the following information. On September 26, 2025, a trust controlled by the Reporting Person (the "Borrower"), entered into a Second Modification Agreement (the "Second Modification Agreement") with Enterprise Bank & Trust (the "Bank") with respect to (i) that certain Promissory Note, dated as of June 20, 2024, by and between the Borrower and the Bank (the "Promissory Note"), (ii) that certain Security Agreement, dated as of June 20, 2024, by and between the Borrower and the Bank (the "Security Agreement"), (iii) that certain Control Agreement, dated as of June 20, 2024, by and between the Borrower and the Bank (the "Control Agreement"), and (iv) that certain First Modification Agreement, dated as of June 15, 2025, by and between the Borrower and the Bank (the "First Modification Agreement" and, collectively with the Second Modification Agreement, the Promissory Note, the Security Agreement and the Control Agreement, the "Loan Documents"). Pursuant to the Loan Documents, the Borrower agreed to pledge to the Bank 3,050,000 shares of Class A Common Stock (the "Collateral") to secure the obligations of the Borrower under the Promissory Note and the other Loan Documents. The obligations of the Borrower under the Loan Documents mature on November 5, 2026. Upon the occurrence of certain events that are customary with this type of transaction, pursuant to the Security Agreement and the Control Agreement, the Bank may exercise its rights to foreclose on, and dispose of, the Collateral in accordance with the Loan Documents. Copies of the Security Agreement and the Control Agreement are attached as Exhibits to this Schedule 13D, and are incorporated herein by reference. Except as set forth herein, the Reporting Person does not have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the New Issuer, including but not limited to any contracts, arrangements, understandings or relationships concerning the transfer or voting of such securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies 5. Security Agreement, dated as of June 20, 2024, by and between the Borrower and the Bank. 6. Control Agreement, dated as of June 20, 2024, by and between the Borrower and the Bank. Patel Dipan Dipan Patel Patel Dipan 10/06/2025